Provide process optimization and scale-up services from small-scale trials to pilot-scale production for cardiovascular devices, surface coating technologies, recombinant humanized collagen-based medical devices, bio-nanomaterial liquid biopsy products, biodegradable materials, and tissue/organ repair products, ensuring a smooth transition from laboratory to large-scale production.

Provide technology development services for biomedical materials and devices to research institutions and enterprises, including new material synthesis, functional modification, product design, etc., to drive technological innovation.

Integrate upstream and downstream resources of the biomedical materials and medical device industry chain, from raw material supply, production processing, to market sales, accelerating the commercialization of research achievements. The products target large and medium-sized hospitals, downstream medical device companies, third-party testing institutions, community services, etc., with a wide application scope.